StockRing.com   Home    DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   
  iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   
 4/25/2014, (NASDAQ:CBST), $66.51 +0.13, +0.20%, "HOLD" Cubist Pharmaceut Stock
 




  
  

CBST rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

On   4/25/2014   StockRing.com recommends to   "HOLD"   CBST   stock at current price of   $66.51.
Today CBST stock opened at $66.55 and was trading in the daily range of $ 65.2082 - 67.50 per share.
Cubist Pharmaceut (NASDAQ:CBST) Market capitalization is $4.975B. CBST average daily volume is 919,498.
On last trading session CBST stock traded 627,771 shares. Also the Short Ratio for (NASDAQ:CBST) stock is 5.40.
Last year Cubist Pharmaceut(NASDAQ:CBST) before taxes (EBITDA) (ttm) earned $154.2M on revenue of $1.054B.
CBST 50-Day Moving Average is $71.47 vs. $66.51 now and 200-Day Moving Average is $69.39 vs. $66.51.
--------------------------------------------------------------------------------------------------------------------
VIX is "HOLD".  Nasdaq is "BUY".  S&P 500 is "BUY" on  4/17/2014
--------------------------------------------------------------------------------------------------------------------
CBST Earnings Per Share - EPS (ttm) is -0.27. CBST Stock Price Per Earnings ratio - P/E is N/A.
Cubist Pharmaceut(NASDAQ:CBST) stock pays a dividend of $0.00 per share which is a yield of N/A%.
On average analysts predict that One Year Target Estimated price for CBST stock is $81.56.
In the last 52 weeks CBST stock was trading in the range of $44.46 - 82.12.
 
 
  Our FREE iPhone App Buy-Sell-Hold ratings for 4573 stocks & ETFs:
 
1. DOW30+    Part 1    199 Stocks    Updated: 4/17/2014 1:36:28 AM
2. DOW30+    Part 2    192 Stocks    Updated: 4/17/2014 1:50:47 AM
3. DOW30+    Part 3    193 Stocks    Updated: 4/17/2014 1:55:09 AM
4. DOW30+    Part 4    195 Stocks    Updated: 4/17/2014 1:59:27 AM
 
5. ENERGY    Part 1    188 Stocks    Updated: 4/18/2014 10:46:27 AM
6. ENERGY    Part 2    186 Stocks    Updated: 4/18/2014 10:51:32 AM
7. ENERGY    Part 3    196 Stocks    Updated: 4/18/2014 10:56:58 AM
 
8. HEALTH    Part 1    184 Stocks    Updated: 4/16/2014 2:02:40 AM
9. HEALTH    Part 2    138 Stocks    Updated: 4/16/2014 2:07:27 AM
 
10. FINANCE    Part 1    191 Stocks    Updated: 11/13/2013 10:58:43 AM
11. FINANCE    Part 2    193 Stocks    Updated: 11/13/2013 12:29:31 PM
12. FINANCE    Part 3    188 Stocks    Updated: 11/13/2013 12:42:47 PM
13. FINANCE    Part 4    188 Stocks    Updated: 11/13/2013 12:46:35 PM
14. FINANCE    Part 5    190 Stocks    Updated: 11/13/2013 10:52:57 AM
 
15. SERVICE    Part 1    181 Stocks    Updated: 4/24/2014 1:06:54 AM
16. SERVICE    Part 2    186 Stocks    Updated: 4/24/2014 1:11:49 AM
17. SERVICE    Part 3    183 Stocks    Updated: 4/24/2014 1:19:16 AM
18. SERVICE    Part 4    193 Stocks    Updated: 4/24/2014 1:33:13 AM
 
19. TECH    Part 1    187 Stocks    Updated: 4/17/2014 11:25:01 PM
20. TECH    Part 2    183 Stocks    Updated: 4/17/2014 11:29:45 PM
21. TECH    Part 3    185 Stocks    Updated: 4/17/2014 11:34:24 PM
22. TECH    Part 4    102 Stocks    Updated: 4/17/2014 11:37:10 PM
 
23. IPOs    200 Stocks    Updated: 4/18/2014 7:17:48 PM
 
24. ETFs    Part 1    193 Stocks    Updated: 4/21/2014 5:56:28 PM
25. ETFs    Part 2    191 Stocks    Updated: 4/21/2014 6:05:32 PM
26. ETFs    Part 3    157 Stocks    Updated: 4/22/2014 2:46:24 AM

BUY  DOW 30+:    ENERGY: CDW  CBA  TSRE  QIWI  EIGI     HEALTH: IEZ  EPHE  FM  JKF  IEO 
      FINANCE: XLK  DWX  GII  SRLN  SLY     SERVICES: TQQQ  MLPX  GLL  DDM  CNPF     TECH: CSGP  WDC  ONNN  RENN  JNPR 
SELL  DOW 30+: GGB     ENERGY: MKTO  Q  HASI  SRLP  TSC     HEALTH: EMFN  MUAC  ISHG  GNMA  SLVP 
      FINANCE: GOVT  SLQD  PGM  JJU  XVZ     SERVICES: UST  YCL  SRTY  MYY  UVXY     TECH: BRKR  CPHD  IPGP  LLTC  MDRX 


Samples of StockRing Real Time "Buy-Sell-Hold" stock Ratings:



  Enter Stock:  
  
    
    
 
 



Download StockRing Free  Buy-Sell-Hold iPhone
App for 1,200 stocks in Energy Healthcare Finance Services & Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH

BUY  DOW 30+:    ENERGY: WPT  WBB  VOYA  VMEM  TSRE     HEALTH: WOOD  TZW  TZV  TZE  TZD 
      FINANCE: XTN  XTL  XSW  XSD  XPH     SERVICES: ZSL  YCS  UYM  UWM  UWC     TECH: WDC  SWIR  RENN  ONNN  NTAP 
SELL  DOW 30+: GGB     ENERGY: XON  XGTI  UBIC  TSC  TNDM     HEALTH: TLH  SLVP  SHV  RING  MUAE 
      FINANCE: XVZ  VXZ  VXX  SLQD  SIL     SERVICES: YCL  VIXY  UVXY  UST  ULE     TECH: YNDX  XRX  XLNX  WIT  WCC 

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

Our FREE iPhone App with Buy-Sell-Hold ratings for 4,030 stocks:

  iPhone App Buy-Sell-Hold Ratings for 5-5-2013
           
           
           
           
     
  

 
  Enter Stock:  
  
    
    
 



4/25/2014  Friday, April 25, 2014 (Irvine, California) Today StockRing.com Recommendation is to "HOLD"for Cubist Pharmaceut (NASDAQ:CBST) Stock. CBST stock opening price was $66.55 per share. Current price of NASDAQ:CBST Stock is $66.51 per share and it is $+0.13, (+0.20%) today and it was trading in the daily range of $65.2082 - 67.50 per share. Current Bid Price for (NASDAQ:CBST) stock is $64.82 and the Ask Price is $68.97. In the last 52 weeks CBST stock was trading in the range of $44.46 - 82.12. 50-Day Moving Average for (NASDAQ:CBST) stock is $71.47 and 200-Day Moving Average is $69.39. On average analysts predict that One Year Target Estimated price for (NASDAQ:CBST) stock is $81.56.

Cubist Pharmaceut (NASDAQ:CBST) is rated as a wait on 4/16/2014 2:11:27 AM.

Cubist Pharmaceut (NASDAQ:CBST) Market capitalization is $4.975B. (NASDAQ:CBST) stock average daily volume is 919,498 shares per day. However, on last trading session of Apr 24, 2012 CBST stock traded 627,771 shares. Also The Number of days it would take short sellers on average to repurchase all the borrowed shares or Short Ratio for (NASDAQ:CBST) stock is 5.40. On previous trading session CBST Stock closed at $66.38 per share.

Last year Cubist Pharmaceut (NASDAQ:CBST) before taxes (EBITDA) (ttm) earned $154.2M on total revenue of $1.054B. Earnings Per Share - EPS (ttm) for CBST stock is -0.27. Thus, (NASDAQ:CBST) Stock Price/Sales (ttm) ratio is 4.71 and Price/Book (mrq) ratio is 3.54.

(NASDAQ:CBST) Stock does NOT PAY any dividend. So at this time (NASDAQ:CBST) Stock maintains Trailing Annual Dividend Rate at 0.00 .


StockRing Recommendations for Cubist Pharmaceut (NASDAQ:CBST) Stock are updated daily here

http://StockRing.com/sr/Buy-Sell-Hold-Stock-Analysis-Ratings.asp?StockName=CBST

At this time StockRing recommends to buy LONG positions on many stocks from Dow 30+ stocks that currently have a BUY or SUPER BUY rating. If you decide to take a SHORT position and actually sell some stocks sjort right now - please check the section of Dow 30+ stocks that have a SELL or SUPER SELL rating.

If you would like to receive Buy-Sell-Hold ratings for stocks from Energy, Healthcare, Finance, Services & Hi-Tech sectors on your iPhone, then please download Buy-Sell-Hold iPhone App here:


Free Limited or $10 Full Version  Buy-Sell-Hold iPhone App
for 1,200 stocks in Energy, Healthcare, Finance, Services and Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH


 
  Enter Stock:  
  
    
    
 
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

NASDAQ:CBST Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info

CBST rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

4/25/2014 1 Year Stock market price chart for Cubist Pharmaceut (NASDAQ:CBST) Stock on Friday, April 25, 2014
  
1 Year CBST 1 Year Dow Jones
1 Year Nasdaq 1 Year S&P 500
4/25/2014 5 days Stock market price chart for Cubist Pharmaceut (NASDAQ:CBST) Stock on Friday, April 25, 2014
  
5 Days CBST 5 Days Dow Jones
5 Days Nasdaq 5 Days S&P 500
  

EUROs for $1 DOLLAR: 30 days
     

NASDAQ:CBST Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

CBST rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

4/25/2014 Stock market price quote data for Cubist Pharmaceut (NASDAQ:CBST) Stock on Friday, April 25, 2014

Last Trade: 66.51
Trade Time: Apr 24
Change: +0.13, (+0.20%)
Prev Close: 66.38
Open: 66.55
Bid: 64.82
Ask: 68.97
1y Target Est: $81.56
50-Day Moving Average: 71.47
200-Day Moving Average:
69.39
Short Ratio: 5.40
Trailing Annual Dividend Rate: 0.00
Day's Range: 65.2082 - 67.50
52wk Range: 44.46 - 82.12
Volume: 627,771
Avg Vol: 919,498
Market Cap: 4.975B
P/E (ttm): N/A
EPS (ttm): -0.27
Div & Yield: 0.00 (N/A%)
Revenue (ttm): 1.054B
Earnings before Tax (EBITDA) (ttm): 154.2M
Price/Sales (ttm): 4.71
Price/Book (mrq): 3.54
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

  
  
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

CBST rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs



4/25/2014 Latest stock market news data for Cubist Pharmaceut (NASDAQ:CBST) Stock on Friday, April 25, 2014

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

CBST rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

Low Cubist Pharmaceuticals Inc (NASDAQ:CBST) Sales Have Led To a Drop in ...
US Trade Media - 13 hours ago
Stock analysts have been closely watching the response to this drug. They wanted to check the performance of the drug's manufacturer in Q1.2014.
Cubist Pharmaceuticals Receives Average Recommendation of “Buy” from ... - WKRB News
Cubist Pharmaceuticals' CEO Discusses Q1 2014 Results - Earnings Call ...
Seeking Alpha - Apr 23, 2014
Good day. My name is Julie, and I'll be your event manager today. At this time, I would like to welcome everyone to the First Quarter 2014 Earnings Conference Call.
Cubist Pharma Posts Weak Earnings on Soft Cubicin Sales
Zacks.com - Apr 23, 2014
Cubist Pharmaceuticals Inc.'s (CBST - Analyst Report) first quarter 2014 earnings (excluding special items) of 10 cents per share fell well short of the Zacks Consensus Estimate of 34 cents due to lower-than-expected revenues.
Cubist Pharmaceuticals Reports First Quarter 2014 Financial Results - Business Wire (press release)
Cubist Pharma Q1 Profit Surges - RTT News
What's Next for Cubist Pharmaceuticals Inc. and Durata Therapeutics, Inc.?
Motley Fool - Apr 4, 2014
Cubist Pharmaceuticals (NASDAQ: CBST ) and Durata Therapeutics (NASDAQ: DRTX ) both won this week with nods by the FDA's advisory panels on each company's antibacterial agents. In two unanimous votes, the FDA panels agreed on the safety and ...
Cubist Pharmaceuticals Issues Recall Due to Glass Particles in Vials
Pharmaceutical Technology Magazine - Apr 21, 2014
Cubist Pharmaceuticals, Inc. announced on April 18 that it is voluntarily recalling one lot of CUBICIN (daptomycin for injection) to the user level due to the presence of particulate matter, reported via customer complaint and identified as glass ...
Cubist Pharmaceuticals Issues Voluntary Recall of Tainted Cubicin Lot
Wall Street Journal - Apr 18, 2014
Cubist Pharmaceuticals Inc. (CBST) said Friday that it is voluntarily recalling a lot of Cubicin treatment after a customer reported finding glass particles in a vial.
Cubist Pharma Recalls One Lot Of Cubicin Due To Presence Of Particulate Matter - RTT News
Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of One Lot of ...
Business Wire (press release) - Apr 18, 2014
LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced it is voluntarily recalling one lot of CUBICIN® (daptomycin for injection) to the user level due to the presence of particulate matter, reported via ...
RSI Alert: Cubist Pharmaceuticals (CBST) Now Oversold
Forbes - Apr 7, 2014
In trading on Monday, shares of Cubist Pharmaceuticals Cubist Pharmaceuticals Inc. (NASD: CBST) entered into oversold territory, hitting an RSI reading of 29.2, after changing hands as low as $65.76 per share.
Cubist Appoints Robert J. Perez to Board of Directors
The Wall Street Transcript - Apr 1, 2014
From 1987 to 1995, Mr. Perez held various sales and marketing positions at Zeneca Pharmaceuticals. Mr. Perez is a Director at AMAG Pharmaceuticals, Inc. and from 2006 - 2009 served as a Director at EPIX Pharmaceuticals, Inc. He is also a Trustee of the ...
Cubist Pharmaceuticals (CBST) to Release Quarterly Earnings on Tuesday
Ticker Report - Apr 21, 2014
Cubist Pharmaceuticals, Inc (NASDAQ:CBST) is a biopharmaceutical company focused on the research, development and commercialization of therapies to treat serious medical conditions in acutely ill patients who are hospitalized or are being treated in ...

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

CBST rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs


4/25/2014 News from StockRing Blog about Cubist Pharmaceut (NASDAQ:CBST) Stock on Friday, April 25, 2014



Copyright © 2012 StockRing.com. All rights reserved.
Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.